MedPath

High-Intensity Interval Training on Pre-Hypertensive Subjects

Not Applicable
Completed
Conditions
Hypertension
Metabolism Disorder
Interventions
Behavioral: High Intensity Interval Training
Behavioral: Control group
Registration Number
NCT03000140
Lead Sponsor
Universidad Santo Tomas
Brief Summary

Despite exercise training decrease blood pressure in 'average' terms, there is a wide interindividual variability after exercise training, being yet unknown what mode of exercise (e.g. endurance, strength, concurrent, or high intensity interval training) produce more/less non-responder (NR) prevalence (i.e., percentage of subjects who experienced a non-change/worsened response after training in some outcome).

Detailed Description

Despite exercise training decrease blood pressure in 'average' terms, there is a wide interindividual variability after exercise training, being yet unknown what mode of exercise (e.g. endurance, strength, concurrent, or high intensity interval training) produce more/less non-responder (NR) prevalence (i.e., percentage of subjects who experienced a non-change/worsened response after training in some outcome).

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
142
Inclusion Criteria
  • Written informed consent;
  • Interested in improving health and fitness;
  • Systolic blood pressure > 120 mmHg and < 140 mmHg, and/or DBP ≥ 80 and < 90 mmHg according with standard classification;
  • No drug therapy during the previous 3 months;
  • Body mass index (BMI) 25 and 35 kg/m2); (c) physically inactive (according to the International Physical Activity Questionnaire previously validated in Chilean population)
  • Normal /mild altered lipid profile (total cholesterol [TC] ~200 and ≤250 mg/dL, low-density lipids [LDL-C] ~140 mg/dL and ≤200 mg/dL, high-density lipids [HDL-C] ≥20 and ~40 mg/dL, triglycerides ~150 and ≤250 mg/dL) according with standard classification.
Exclusion Criteria
  • Cardiovascular contraindications to exercise histories of stroke;
  • Asthma and chronic obstructive pulmonary disease;
  • Musculoskeletal disorder such as low back pain;
  • Smokers in the last 3 months were not included in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High Intensity Interval TrainingHigh Intensity Interval TrainingCycling on cycle ergometers (OXFORDTM, model BE2601, OXOFORD Inc, Santiago, Chile) for 1 min at a subjective intensity of 8-10 points of the modified Borg scale of 1-10 points, and interspersed by inactive (without movement over the bicycle) of 2 minutes as recovery period.
Control groupControl groupPre-hypertensive group was compared with healthy groups in the 2 manin variables systolic/diastolic blood pressure, as well as in other co-variables in pre-post changes. Thus, after the training intervention, and following the R and NR classification, we will compare the NR prevalence between both Pre-hypertensive and Healthy group.
Primary Outcome Measures
NameTimeMethod
Change from Baseline in systolic blood pressure and diastolic blood pressureBaseline and 16 weeks immediately after the interventions ends

After this, we calculated the delta changes in both variables and classified to all subjects in responders (R) and non-responders (NR) to decrease systolic or diastolic blood pressure.

Secondary Outcome Measures
NameTimeMethod
Change from Baseline in waist circumferenceBaseline and 16 weeks immediately after the interventions ends
Change from Baseline in fat massBaseline and 16 weeks immediately after the interventions ends
Change from Baseline in body mass indexBaseline and 16 weeks immediately after the interventions ends

BMI will be calculated as the body weight in kilograms divided by the square of the height in meters.

Change from Baseline in body massBaseline and 16 weeks immediately after the interventions ends
Change from Baseline in one maximum repetition strength test of leg-extension exerciseBaseline and 16 weeks immediately after the interventions ends
Change from Baseline in heart rate at restBaseline and 16 weeks immediately after the interventions ends

Baseline and 16 weeks immediately after the interventions ends

Change from Baseline in fasting glucoseBaseline and 16 weeks immediately after the interventions ends
Change from Baseline in lipidsBaseline and 16 weeks immediately after the interventions ends

Lipid profile (low-density cholesterol, total cholesterol, high-density cholesterol and triglycerides)

Trial Locations

Locations (1)

Cristian Alvarez

🇨🇱

Osorno, Chile

© Copyright 2025. All Rights Reserved by MedPath